D-α-Tocopherol polyethylene glycol succinate (TPGS), an inhibitor of the permeability glycoprotein (Pgp, a multidrug resistance protein), was included in the NP to inhibit Pgp expression in drug-resistant cancer cells. This evidence concerns the gene PGP and cancer.